Evaluating the Performance of High-Dimensional Propensity Scores Compared with Standard Propensity Scores for

Virginie Simon1, Jade Vadel2

  • 1Global Real World Evidence, Institut de Recherches Internationales Servier (IRIS), Suresnes, France. virginie.simon@servier.com.

Insights

High-dimensional propensity score (hdPS) matching effectively identifies confounding variables for comparing antihypertensive therapies. Both hdPS and propensity score (PS) matching confirm bitherapy is superior to monotherapy for blood pressure control.

Area of Science:

  • Epidemiology and Biostatistics
  • Health Services Research
  • Pharmacotherapy Research

Background:

  • Propensity score (PS) matching is a standard method for creating balanced treatment groups in medical record studies, but requires pre-defined confounding factors.
  • High-dimensional propensity score (hdPS) is a semi-automated algorithm designed to identify potential confounders from large medical databases.

Purpose of the Study:

  • To evaluate and compare the performance of hdPS and traditional PS matching.
  • To assess the effectiveness of these methods in analyzing antihypertensive therapies using the UK Clinical Practice Research Datalink (CPRD) GOLD database.

Main Methods:

  • Utilized plasmode simulations with a marginal hazard ratio (HRm) of 1.29 for bitherapy vs. monotherapy for blood pressure control at 3 months.
  • Compared hdPS and PS models using either 16 or 36 known covariates, with hdPS additionally selecting 200 variables automatically.
  • Conducted sensitivity analyses to evaluate hdPS performance after removing known confounders.

Main Results:

  • With 36 covariates, hdPS yielded HRm 1.31 (RMSE 0.05) and PS matching yielded HRm 1.30 (RMSE 0.04).
  • With 16 covariates, hdPS yielded HRm 1.23 (RMSE 0.10) and PS yielded HRm 1.09 (RMSE 0.20).
  • hdPS performance remained robust even when known confounders were excluded from the analysis.

Conclusions:

  • High-dimensional propensity score (hdPS) can identify proxies for unobserved confounders, offering an advantage over traditional PS matching.
  • Both PS and hdPS methods demonstrated that bitherapy is superior to monotherapy for achieving blood pressure control.
Abstract

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
173
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
232
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
313
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
115
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.0K